The current PE ratio for Prestige Consumer Healthcare stock as of Apr 2, 2025 is 19.96. This is calculated based on the current EPS of $4.31 and the stock price of $86.03 per share. The P/E ratio has an increase of 15% from the past four quarters average of 17.4.
The average historical PE ratio of Prestige Consumer Healthcare for the last ten years is 19.14. The current PE ratio of 19.96 is 4.3% above the historical average. Over the past ten years, PBH's PE ratio was at its highest in the Jun 2016 quarter at 42.95, when the stock price was $55.4 and the EPS was $1.29. The lowest value was in the Mar 2018 quarter, when it reached 5.27 with a price of $33.72 and an EPS of $6.4.
Maximum annual increase: 50.12% in 2017
Maximum annual decrease: -87.57% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 17.24 | N/A | $72.56 | $4.21 |
2023 | N/A | N/A | $62.63 | -$1.65 |
2022 | 12.94 | -3.72% | $52.94 | $4.09 |
2021 | 13.44 | 2.99% | $44.08 | $3.28 |
2020 | 13.05 | N/A | $36.68 | $2.81 |
2019 | N/A | N/A | $29.91 | -$0.69 |
2018 | 5.27 | -87.57% | $33.72 | $6.4 |
2017 | 42.41 | 50.12% | $55.56 | $1.31 |
2016 | 28.25 | -1.19% | $53.39 | $1.89 |
2015 | 28.59 | 47.9% | $42.89 | $1.5 |
2014 | 19.33 | -2.91% | $27.25 | $1.41 |
2013 | 19.91 | -15.71% | $25.69 | $1.29 |
2012 | 23.62 | 19.11% | $17.48 | $0.74 |
2011 | 19.83 | 41.04% | $11.5 | $0.58 |
2010 | 14.06 | N/A | $9 | $0.64 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 18.12 | 4.32% | $78.09 | $4.31 |
Sep 2024 | 17.37 | 4.2% | $72.1 | $4.15 |
Jun 2024 | 16.67 | -3.31% | $68.85 | $4.13 |
Mar 2024 | 17.24 | N/A | $72.56 | $4.21 |
Dec 2023 | N/A | N/A | $61.22 | -$1.6 |
Sep 2023 | N/A | N/A | $57.19 | -$1.62 |
Jun 2023 | N/A | N/A | $59.43 | -$1.68 |
Mar 2023 | N/A | N/A | $62.63 | -$1.65 |
Dec 2022 | 14.87 | 24.12% | $62.6 | $4.21 |
Sep 2022 | 11.98 | -17.66% | $49.83 | $4.16 |
Jun 2022 | 14.55 | 12.44% | $58.8 | $4.04 |
Mar 2022 | 12.94 | -19.78% | $52.94 | $4.09 |
Dec 2021 | 16.13 | 2.61% | $60.65 | $3.76 |
Sep 2021 | 15.72 | 7.45% | $56.11 | $3.57 |
Jun 2021 | 14.63 | 8.85% | $52.1 | $3.56 |
PBH's current P/E ratio is above the 3, 5 and 10-year historical averages.
PBH's PE ratio is lower than its peer stocks PG and JNJ, but it is greater than ABT's and NVS's. Prestige Consumer Healthcare's current PE ratio of 19.96 is below the average of its peers, which is 23.55.
Stock name | PE ratio | Market cap |
---|---|---|
ABT Abbott Laboratories | 17.26 | $229.66B |
PFE Pfizer Inc | 17.28 | $139.05B |
CVS CVS HEALTH Corp | 18.74 | $86.69B |
NVS Novartis AG | 19.05 | $222.73B |
PBH Prestige Consumer Healthcare Inc | 19.77 | $4.22B |
PG PROCTER & GAMBLE Co | 26.84 | $405.24B |
JNJ Johnson & Johnson | 27.47 | $386.21B |
CLX Clorox Co | 40.35 | $18.29B |
The price to earnings ratio for PBH stock is 19.96 as of Apr 2, 2025.
The average PE ratio for PBH stock over the past 3 years is 15.83.
The average PE ratio for PBH stock over the past 5 years is 14.52.
In the last ten years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 42.95.
The current price to earnings ratio of PBH is 4.3% higher than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 2, 2025), Prestige Consumer Healthcare's stock price is $86.03. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $4.31. Therefore, Prestige Consumer Healthcare's P/E ratio for today is 19.96. PE RATIO(19.96) = STOCK PRICE($86.03) / TTM EPS($4.31)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.